Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited - pharma in Matoda, Gujarat, India. Directors, charges & compliance details.
CIN U24230GJ2005PLC046915 Incorporated 14 October 2005 ROC Ahmedabad HQ Matoda, Gujarat, India
Merged Public Limited Company pharma
Data last updated
Revenue · FY 2019
₹57.16 Cr
▼ 60% YoY
Net loss · FY 2019
₹13.75 Cr
Net margin -24.1%
EBITDA · FY 2019
-₹14.86 Cr
EBITDA margin -26%
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹99.33 Cr
Issued & subscribed
Satisfied charges
₹35 Cr
No open charges
Company age
21 yrs
Est. 2005
Employees · EPFO
242
Provident fund records

About Alidac Pharmaceuticals Limited

Data last updated:

Alidac Pharmaceuticals Limited was a public limited company based in Matoda, Gujarat, India, operated as a subsidiary of Cadila Healthcare Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 14 October 2005.

The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PLC046915. The company has 2 GST registrations on record, none of which is active.

The company had an authorised share capital of ₹100 Cr and a paid-up capital of ₹99.33 Cr. It was formerly known as Zydus Bsv Pharma Private Limited. and Alidac Pharmaceuticals Private Limited. It was led by directors including Ganesh Narayan Nayak and Kshitish Madanmohan Shah.

Its last annual general meeting (AGM) was held on 30 July 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Plot No. 1A Pharmez Sarkhej – Bavla N.H. No. 8A, Matoda, Gujarat, India – 382213.

As per the financials filed for FY 2019, the company reported a revenue of ₹57.16 Cr, a decline of 60% compared to the previous year. For the same year it recorded a net loss of ₹13.75 Cr (net margin -24.1%) and EBITDA of -₹14.86 Cr (EBITDA margin -26%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.

The company had about 242 employees on its provident fund (EPFO) records before it was dissolved.

As per MCA filings, the company had satisfied charges of ₹35 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 1 deal on record (1 acquisition); the latest was in March 2015. Its 10 peer companies in the Pharma industry (Contract Research, Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Excel Biolife Private Limited with revenue of ₹57.71 Cr.

The last known website on record is alidac.com.

Company Details of Alidac Pharmaceuticals Limited
CIN U24230GJ2005PLC046915
Registration Number 046915
Incorporation Date 14 October 2005
ROC Ahmedabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 July 2019
Date of Balance Sheet 31 March 2019
Parent Company Cadila Healthcare Limited
Compliance Status Active Compliant

Name History of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals has undergone 4 name changes throughout its history. The current legal name is Alidac Pharmaceuticals Limited.

Company NameStatus
Alidac Pharmaceuticals LimitedCurrent
Zydus Bsv Pharma Private Limited.Previous
Alidac Pharmaceuticals Private LimitedPrevious
Bsv Pharma Private Limited.Previous
Bsv Pharma Private LimitedPrevious

CIN History of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230GJ2005PTC046915. The current CIN is U24230GJ2005PLC046915, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230GJ2005PLC046915Current
U24230GJ2005PTC046915Previous
Key People
Ganesh Narayan Nayak Director Kshitish Madanmohan Shah Director Subodhchandra Purushottamdas Adeshara Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. 1A Pharmez Sarkhej – Bavla N.H. No. 8A, Matoda, Gujarat, India – 382213
  • Industry
    Pharma, Pharma Contract R&D, Drug Formulation & Development
Comprehensive company report
Alidac Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Alidac Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Alidac Pharmaceuticals Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Alidac Pharmaceuticals Limited

The main business activity of Alidac Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Alidac Pharmaceuticals Limited FY 2019 filings available

Alidac Pharmaceuticals Limited reported revenue of ₹57.16 Cr (down 60% YoY) for FY 2019.

Revenue · FY 2019
₹57.16 Cr ▼ 60%
Net loss · FY 2019
₹13.75 Cr margin -24.1%
EBITDA · FY 2019
-₹14.86 Cr margin -26%

Compounded Annual Growth Rate (CAGR) of Alidac Pharmaceuticals Limited

Revenue CAGR growth
1 year
▼ 60%
3 years · compounded
▼ 17%
EBITDA CAGR growth
1 year
▼ 171%
3 years · compounded
▼ 37%

Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 60% fall in the latest year. EBITDA fell 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Alidac Pharmaceuticals Limited

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue₹57.16 Cr••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹14.86 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹13.75 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Alidac Pharmaceuticals Limited

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-26%••••••••••••••••
Net Profit Margin-24.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Alidac Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals has 4 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Ganesh Narayan Nayak
Also directs: Zydus Wellness Limited, Zydus Lifesciences Limited, Zydus Hospira Oncology Private Limited and 3 more
Director07 Apr 200620 Years 6 MonthsAs last reported
Kshitish Madanmohan Shah
Also directs: Shree Vyankateswar Engineering Pvt Ltd, 21St Century Equipments Private Limited, M Ramanlal Holdings Pvt Ltd and 2 more
Director27 Jul 201511 Years 2 MonthsAs last reported
Subodhchandra Purushottamdas Adeshara
Also directs: Shri Bhupendra V. Patel Education Foundation
Director27 Jul 201511 Years 2 MonthsAs last reported
Nitinkumar Dalsukhray Parekh
Also directs: Newleaf Consultants LLP
Director17 Jun 201412 Years 4 MonthsAs last reported
View all directors

Peer Comparison of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Excel Biolife Private Limited₹57.71 Cr (FY 2023)••••••••4.0%••••Mumbai, Maharashtra, India
And Healthcare Limited₹57.48 Cr (FY 2024)••••••••24.0%••••Mohali, Punjab, India
Alna Biotech Private Limited₹57.47 Cr (FY 2024)••••••••3.0%••••Chandigarh, India
Accretion Pharmaceuticals Limited₹57.47 Cr (FY 2025)••••••••329.0%••••Sanand, Gujarat, India
VPL Chemicals Private Limited₹57.32 Cr (FY 2025)••••••••23.0%••••Bangalore, Karnataka, India
Alidac Pharmaceuticals Limited this company₹57.16 Cr (FY 2019)••••••••-60.0%••••Matoda, Gujarat, India
Samrat Remedies India Private Limited₹57.12 Cr (FY 2024)••••••••29.0%••••Mumbai, Maharashtra, India
Varav Biogenesis Private Limited₹56.89 Cr (FY 2024)••••••••-6.0%••••Panipat, Haryana, India
Ikon Remedies Private Limited₹56.85 Cr (FY 2024)••••••••-15.0%••••Nagpur, Maharashtra, India
Eurofins Peenya Resources Private Limited₹56.82 Cr (FY 2025)••••••••-8.0%••••Bangalore - 560 058, Karnataka, India
Micropure Parenterals Private Limited₹56.66 Cr (FY 2025)••••••••37.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Alidac Pharmaceuticals by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited is audited by SORAB S ENGINEER & CO for the financial year 2019.

NameStatusAppointment DateCessation Date
SORAB S ENGINEER & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Alidac Pharmaceuticals Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Alidac Pharmaceuticals Limited

Open charges
None
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Export-Import Bank of India₹35.00 Cr
Latest charge details
DateLenderAmountStatus
25 Aug 2008Export-Import Bank of India₹35 CrSatisfied

Total charge records: 1 View all charges

Deals & Funding of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited has 1 deal on record (1 acquisition); the latest was in March 2015.

Total deals
1
Acquisition
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2015AcquisitionUndisclosedBuyer: Zydus Lifesciences Limited
Seller: Bharat Serums And Vaccines Limited
Premium access

Full deal history

All 1 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited has a workforce of 242 employees as of Apr 07, 2024.

Employee count
242
Active EPFO establishments
1
Employee growth
-0.82%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals Limited has 20 board changes on record since 2006: 4 appointments and 16 cessations. The latest: Rashminkumar Bipinchandra Shah ceased to be Ceo(Kmp) on 31 Jan 2019.

AGM
Alidac Pharmaceuticals Limited last Annual general meeting of members was held on 30 Jul 2019 as per latest MCA records.
Filing
Alidac Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad.
Ceased
Rashminkumar Bipinchandra Shah ceased to be Ceo(Kmp).
Ceased
Madhav Kulkarni Shripadrao ceased to be Director.
Ceased
Kshitish Madanmohan Shah ceased to be Additional Director.
Ceased
Subodhchandra Purushottamdas Adeshara ceased to be Additional Director.
Appointed
Kshitish Madanmohan Shah was appointed as Director.
Appointed
Subodhchandra Purushottamdas Adeshara was appointed as Director.
Ceased
Gautam Vinod Daftary ceased to be Nominee Director.
Ceased
Girish Bakre ceased to be Director.
Ceased
Nitinkumar Dalsukhray Parekh ceased to be Director Appointed In Casual Vacancy.
Appointed
Nitinkumar Dalsukhray Parekh was appointed as Director.

14 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Alidac Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Alidac Pharmaceuticals Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Alidac Pharmaceuticals Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Alidac Pharmaceuticals Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alidac Pharmaceuticals Limited

Alidac Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Alidac Pharmaceuticals was a public limited company based in Matoda, Gujarat, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 14 October 2005 and is registered under CIN U24230GJ2005PLC046915. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Alidac Pharmaceuticals was incorporated on 14 October 2005. It is registered with the Registrar of Companies, Ahmedabad.

Alidac Pharmaceuticals had 4 directors:

The CIN (Corporate Identification Number) of Alidac Pharmaceuticals is U24230GJ2005PLC046915. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Alidac Pharmaceuticals is at Plot No. 1A Pharmez Sarkhej – Bavla N.H. No. 8A, Matoda, Gujarat, India – 382213.

Alidac Pharmaceuticals can be reached through the website alidac.com. Its registered office is in Matoda, Gujarat, India.

Alidac Pharmaceuticals reported revenue of ₹57.16 Cr for FY 2019 (down 60% YoY).

Alidac Pharmaceuticals has an authorised share capital of ₹100 Cr and a paid-up capital of ₹99.33 Cr.

Alidac Pharmaceuticals reported a net loss of ₹13.75 Cr (net margin -24.1%) and EBITDA of -₹14.86 Cr (EBITDA margin -26%) for FY 2019, as per its filed financial statements.

No. Alidac Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available